Structure Therapeutics GPCR
NASDAQ GPCR
$22.36 -0.52 (-2.27%)
As of: Oct 21, 2026 · 11:41 AM EDT

Structure Therapeutics (GPCR) Deferred Taxes (2022)

Updated

Structure Therapeutics (GPCR) reported Deferred Taxes of -$115,000 for Q2 2022.

Analysis

Structure Therapeutics (GPCR) Deferred Taxes (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 1.05 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn -479.00 Mn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn -195.00 Mn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn -544.00 Mn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn -
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn -
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn -291.00 Mn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn -587.00 Mn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn -1.32 Bn
10 Structure Therapeutics 4.88 Bn 3.53 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 115,000.00
Mar 31, 2022 6,000.00
API Access

Structure Therapeutics Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=GPCR&period=max&api_key=YOUR_API_KEY